Gross profit increased 0.6%
Gross profit changed +0.6% from the comparable as-filed period.
$490.0M→$493.0M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →XRAY financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents decreased 33.4%
Cash & equivalents changed -33.4% from the comparable as-filed period.
$359.0M→$239.0M2 prior comparisons
Net income increased 182.2%
Net income changed +182.2% from the comparable as-filed period.
-$45.0M→$37.0M2 prior comparisons
Operating income increased 164.1%
Operating income changed +164.1% from the comparable as-filed period.
-$128.0M→$82.0M3 prior comparisons
Operating margin moved 2281 bp higher
Operating margin changed +2281 basis points from the comparable as-filed period.
-13.68%→9.13%3 prior comparisons
Research & development increased 21.6%
Research & development changed +21.6% from the comparable as-filed period.
$37.0M→$45.0M3 prior comparisons
Gross margin moved 255 bp higher
Gross margin changed +255 basis points from the comparable as-filed period.
52.35%→54.90%3 prior comparisons
Selling, general & administrative increased 6.4%
Selling, general & administrative changed +6.4% from the comparable as-filed period.
$342.0M→$364.0M3 prior comparisons
Inventory decreased 1.5%
Inventory changed -1.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$675.0M→$665.0M4 prior comparisons
Revenue decreased 4.1%
Revenue changed -4.1% from the comparable as-filed period.
$936.0M→$898.0M3 prior comparisons
Stock-based compensation unchangedd 0.0%
Stock-based compensation changed +0.0% from the comparable as-filed period.
$9.0M→$9.0M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.